vs
Side-by-side financial comparison of FREQUENCY ELECTRONICS INC (FEIM) and Spero Therapeutics, Inc. (SPRO). Click either name above to swap in a different company.
FREQUENCY ELECTRONICS INC is the larger business by last-quarter revenue ($17.1M vs $12.6M, roughly 1.4× Spero Therapeutics, Inc.). Spero Therapeutics, Inc. runs the higher net margin — 250.7% vs 10.5%, a 240.2% gap on every dollar of revenue. On growth, Spero Therapeutics, Inc. posted the faster year-over-year revenue change (24080.8% vs 8.3%). Over the past eight quarters, Spero Therapeutics, Inc.'s revenue compounded faster (847.7% CAGR vs 11.8%).
Ultra Electronics Holdings is a British defence and security company. It was listed on the London Stock Exchange and was a constituent of the FTSE 250 Index until it was acquired by Cobham, which is itself owned by Advent International.
FEIM vs SPRO — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $17.1M | $12.6M |
| Net Profit | $1.8M | $31.5M |
| Gross Margin | 38.2% | — |
| Operating Margin | 10.0% | — |
| Net Margin | 10.5% | 250.7% |
| Revenue YoY | 8.3% | 24080.8% |
| Net Profit YoY | -32.1% | 250.9% |
| EPS (diluted) | $0.18 | $0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $17.1M | $12.6M | ||
| Q3 25 | $13.8M | $0 | ||
| Q2 25 | $20.0M | $0 | ||
| Q1 25 | $18.9M | $12.0K | ||
| Q4 24 | $15.8M | $52.0K | ||
| Q3 24 | $15.1M | $65.0K | ||
| Q2 24 | $15.6M | $114.0K | ||
| Q1 24 | $13.7M | $140.0K |
| Q4 25 | $1.8M | $31.5M | ||
| Q3 25 | $634.0K | $-7.4M | ||
| Q2 25 | $3.2M | $-1.7M | ||
| Q1 25 | $15.4M | $-13.9M | ||
| Q4 24 | $2.7M | — | ||
| Q3 24 | $2.4M | $-17.1M | ||
| Q2 24 | $2.6M | $-17.9M | ||
| Q1 24 | $130.0K | $-12.7M |
| Q4 25 | 38.2% | — | ||
| Q3 25 | 36.8% | — | ||
| Q2 25 | 37.5% | — | ||
| Q1 25 | 43.8% | — | ||
| Q4 24 | 48.2% | — | ||
| Q3 24 | 44.4% | — | ||
| Q2 24 | 40.3% | — | ||
| Q1 24 | 22.6% | — |
| Q4 25 | 10.0% | — | ||
| Q3 25 | 2.6% | — | ||
| Q2 25 | 16.4% | — | ||
| Q1 25 | 18.3% | -122758.3% | ||
| Q4 24 | 16.5% | — | ||
| Q3 24 | 15.7% | -28604.6% | ||
| Q2 24 | 16.0% | -16720.2% | ||
| Q1 24 | -3.4% | -9987.1% |
| Q4 25 | 10.5% | 250.7% | ||
| Q3 25 | 4.6% | — | ||
| Q2 25 | 16.0% | — | ||
| Q1 25 | 81.4% | -115550.0% | ||
| Q4 24 | 16.8% | — | ||
| Q3 24 | 16.1% | -26380.0% | ||
| Q2 24 | 16.9% | -15668.4% | ||
| Q1 24 | 0.9% | -9049.3% |
| Q4 25 | $0.18 | $0.56 | ||
| Q3 25 | $0.07 | $-0.13 | ||
| Q2 25 | $0.33 | $-0.03 | ||
| Q1 25 | $1.60 | $-0.25 | ||
| Q4 24 | $0.28 | — | ||
| Q3 24 | $0.25 | $-0.32 | ||
| Q2 24 | $0.28 | $-0.33 | ||
| Q1 24 | $0.01 | $-0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.0M | $40.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $58.5M | $59.0M |
| Total Assets | $92.3M | $68.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.0M | $40.3M | ||
| Q3 25 | $4.5M | $48.6M | ||
| Q2 25 | $4.7M | $31.2M | ||
| Q1 25 | $5.5M | $48.9M | ||
| Q4 24 | $9.7M | $52.9M | ||
| Q3 24 | $16.2M | $76.3M | ||
| Q2 24 | $18.3M | $63.5M | ||
| Q1 24 | $11.7M | $82.3M |
| Q4 25 | $58.5M | $59.0M | ||
| Q3 25 | $56.3M | $26.5M | ||
| Q2 25 | $55.6M | $32.8M | ||
| Q1 25 | $51.8M | $33.8M | ||
| Q4 24 | $36.2M | $46.1M | ||
| Q3 24 | $33.2M | $65.5M | ||
| Q2 24 | $39.8M | $80.5M | ||
| Q1 24 | $36.7M | $96.2M |
| Q4 25 | $92.3M | $68.9M | ||
| Q3 25 | $93.2M | $54.2M | ||
| Q2 25 | $93.7M | $62.1M | ||
| Q1 25 | $86.4M | $77.7M | ||
| Q4 24 | $77.8M | $110.5M | ||
| Q3 24 | $84.3M | $135.2M | ||
| Q2 24 | $83.3M | $149.9M | ||
| Q1 24 | $77.7M | $167.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-523.0K | $-8.4M |
| Free Cash FlowOCF − Capex | $-1.1M | — |
| FCF MarginFCF / Revenue | -6.6% | — |
| Capex IntensityCapex / Revenue | 3.6% | — |
| Cash ConversionOCF / Net Profit | -0.29× | -0.26× |
| TTM Free Cash FlowTrailing 4 quarters | $-5.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-523.0K | $-8.4M | ||
| Q3 25 | $1.2M | $17.4M | ||
| Q2 25 | $-155.0K | $-17.7M | ||
| Q1 25 | $-3.6M | $-4.0M | ||
| Q4 24 | $3.8M | $-23.4M | ||
| Q3 24 | $-1.5M | $12.8M | ||
| Q2 24 | $7.5M | $-18.7M | ||
| Q1 24 | $4.2M | $5.9M |
| Q4 25 | $-1.1M | — | ||
| Q3 25 | $385.0K | — | ||
| Q2 25 | $-786.0K | — | ||
| Q1 25 | $-4.0M | — | ||
| Q4 24 | $3.3M | — | ||
| Q3 24 | $-1.8M | — | ||
| Q2 24 | $6.7M | — | ||
| Q1 24 | $3.9M | — |
| Q4 25 | -6.6% | — | ||
| Q3 25 | 2.8% | — | ||
| Q2 25 | -3.9% | — | ||
| Q1 25 | -20.9% | — | ||
| Q4 24 | 20.8% | — | ||
| Q3 24 | -11.8% | — | ||
| Q2 24 | 42.8% | — | ||
| Q1 24 | 28.4% | — |
| Q4 25 | 3.6% | — | ||
| Q3 25 | 5.6% | — | ||
| Q2 25 | 3.2% | — | ||
| Q1 25 | 1.7% | — | ||
| Q4 24 | 3.3% | — | ||
| Q3 24 | 2.2% | — | ||
| Q2 24 | 5.3% | — | ||
| Q1 24 | 2.3% | — |
| Q4 25 | -0.29× | -0.26× | ||
| Q3 25 | 1.83× | — | ||
| Q2 25 | -0.05× | — | ||
| Q1 25 | -0.24× | — | ||
| Q4 24 | 1.44× | — | ||
| Q3 24 | -0.60× | — | ||
| Q2 24 | 2.85× | — | ||
| Q1 24 | 32.36× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FEIM
| POC Revenue | $14.8M | 86% |
| POT Revenue | $2.3M | 13% |
SPRO
Segment breakdown not available.
